PARMAX.BO
Price:
$34.75
Market Cap:
$130.01M
Parmax Pharma Ltd. engages in the manufacture of bulk drugs like ampicilin, amoxycillin, cephalexin, and nalidixic acid. The company also plans to extend its activities in formulation of tablets, capsules, ointments, & injectable. The company was founded on November 2, 1994 and is headquartered in Rajkot, India.
Industry
Medical - Pharmaceuticals
IPO Date
Stock Exchange
BSE
Ticker
PARMAX.BO
According to Parmax Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is -4.46. This represents a change of -53.41% compared to the average of -9.57 of the last 4 quarters.
The mean historical PE Ratio of Parmax Pharma Limited over the last ten years is 1.28K. The current -4.46 PE Ratio has changed -134.96% with respect to the historical average. Over the past ten years (40 quarters), PARMAX.BO's PE Ratio was at its highest in in the September 2016 quarter at 1.13K. The PE Ratio was at its lowest in in the December 2016 quarter at -312.51.
Average
1.28K
Median
6.98
Minimum
-108.40
Maximum
12.65K
Discovering the peaks and valleys of Parmax Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 12.65K
Minimum Annual Increase = 0%
Minimum Annual PE Ratio = -108.40
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -8.07 | 841.21% |
| 2024 | -0.86 | -99.21% |
| 2023 | -108.40 | -200.37% |
| 2022 | 108.00 | 513.49% |
| 2021 | 17.60 | 26.08% |
| 2020 | 13.96 | -83.02% |
| 2019 | 82.24 | -99.35% |
| 2018 | 12.65K | Infinity% |
| 2017 | 0 | 0% |
| 2016 | 0 | 0% |
The current PE Ratio of Parmax Pharma Limited (PARMAX.BO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-39.11
5-year avg
1.65
10-year avg
1.28K
Parmax Pharma Limited’s PE Ratio is less than Evoq Remedies Limited (4.38), less than Cian Healthcare Limited (-0.62), less than Beryl Drugs Limited (49.41), less than Decipher Labs Ltd. (-1.06), less than Colinz Laboratories Limited (22.83), less than Emmessar Biotech & Nutrition Limited (36.91), greater than Gian Life Care Limited (-148.56), greater than Shamrock Industrial Co. Ltd. (-54.62), greater than Vivanza Biosciences Limited (-11.23), greater than Span Divergent Limited (-17.26),
| Company | PE Ratio | Market cap |
|---|---|---|
| 4.38 | $70.97M | |
| -0.62 | $137.73M | |
| 49.41 | $110.26M | |
| -1.06 | $100.39M | |
| 22.83 | $105.80M | |
| 36.91 | $145.89M | |
| -148.56 | $107.66M | |
| -54.62 | $100.32M | |
| -11.23 | $88.00M | |
| -17.26 | $174.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Parmax Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Parmax Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Parmax Pharma Limited's PE Ratio?
How is the PE Ratio calculated for Parmax Pharma Limited (PARMAX.BO)?
What is the highest PE Ratio for Parmax Pharma Limited (PARMAX.BO)?
What is the 3-year average PE Ratio for Parmax Pharma Limited (PARMAX.BO)?
What is the 5-year average PE Ratio for Parmax Pharma Limited (PARMAX.BO)?
How does the current PE Ratio for Parmax Pharma Limited (PARMAX.BO) compare to its historical average?